Trial Profile
A multi-center, randomized, double-blind, placebo-controlled efficacy and safety study of testosterone gel 1.62% for the treatment of hypogonadal men.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 18 Jul 2023
Price :
$35
*
At a glance
- Drugs Testosterone (Primary)
- Indications Hypogonadism
- Focus Pharmacokinetics; Therapeutic Use
- 01 Jul 2011 Results published in the Journal of Sexual Medicine.
- 22 Jun 2010 Results presented at the 92nd Annual Meeting of the Endocrine Society
- 22 Jun 2010 Results presented at the 92nd Annual Meeting of the Endocrine Society